The Effects of Cognitive-motor Dual-task Intervention on Fall Prevention Among Older Adults

Launched by JINYAO WANG · Jun 9, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new type of exercise program designed to help older adults reduce their risk of falling. The program combines thinking tasks with physical movements, using fun and interactive games to make the activities more engaging. The goal is to see if this "dual-task" approach can better prevent falls by improving both the mind and body at the same time, and to understand how it works to keep people steady and safe.

Older adults who are 65 years or older, able to walk on their own without pain or difficulty, and have a low to moderate risk of falling might be eligible to join. Participants should have no serious health problems affecting their movement or thinking, such as severe heart or brain conditions, and need to be able to understand instructions and communicate clearly. During the study, participants will take part in the specially designed exercise sessions with the gamified tasks. This trial is not yet open for enrollment, but it aims to offer a fun and effective way to help older adults stay balanced and reduce falls.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥ 65 years old;
• • 2. Able to walk independently for at least 10 meters without obvious pain or difficulty;
• • 3. Free from lower limb and foot deformities, wounds, ulcers, or other diseases, and capable of wearing flexible devices;
• • 4. Scored as low or moderate fall risk on the Morse Fall Risk Assessment Scale;
• • 5. Scored \> 40 points on the Berg Balance Scale and \< 20 seconds on the Time Up and Go Test (TUG);
• • 6. Scored ≥ 21 points on the Mini-Mental State Examination (MMSE);
• • 7. With an educational level of primary school or above, able to correctly understand instructions and make corresponding responses;
• • 8. Without diseases that severely affect cognitive and motor functions, including cardiovascular diseases (such as uncontrolled hypertension, heart failure, etc.), neurological diseases (such as Parkinson's disease, stroke, epilepsy, etc.), musculoskeletal diseases (such as severe arthritis, recent fractures, etc.), etc.;
• • 9. Normal vision and hearing or corrected to normal, without affecting the understanding of instructions and participation in interventions;
• • 10. Conscious and able to understand the test requirements;
• • 11. Able to understand and sign the informed consent form voluntarily, and willing to cooperate in completing the research procedures.
• Exclusion Criteria:
• • 1. Must rely on assistive walking devices or others to walk;
• • 2. Individuals with color vision disorders, including various types of color blindness and color weakness;
• • 3. Unable to correctly perform addition and subtraction operations;
• • 4. Those allergic to the materials of research equipment;
• • 5. Currently participating in other research or intervention projects that may affect the effectiveness of this intervention.